• October 19, 2019

Arcus Biosciences to Present at the 2019 Cantor Global Healthcare Conference - Odessa American: Business

e-Edition Subscribe

Arcus Biosciences to Present at the 2019 Cantor Global Healthcare Conference

Print
Font Size:
Default font size
Larger font size

Posted: Thursday, September 19, 2019 3:31 pm | Updated: 4:00 pm, Thu Sep 19, 2019.

HAYWARD, Calif.--(BUSINESS WIRE)--Sep 19, 2019--

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer therapies, today announced that Terry Rosen, Ph.D., Chief Executive Officer, will present at the 2019 Cantor Global Healthcare Conference on Friday, October 4, 2019 at 9:30 a.m. Eastern Time in New York, NY.

A live audio webcast of the presentation will be available by visiting the “Investors” section of the Arcus website at www.arcusbio.com. A replay of the webcast will be available for at least 30 days following the live event.

About Arcus Biosciences

Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating innovative cancer therapies. Arcus has four programs in the clinic targeting important oncology/immuno-oncology pathways: (1) AB928, a dual adenosine receptor antagonist (A 2a and A 2b receptors), being evaluated in several Phase 1/1b trials in combination with multiple regimens across a range of tumor types, (2) AB680, a small molecule inhibitor of CD73 progressing into a Phase 1/1b pancreatic cancer trial, (3) AB122, an anti-PD-1 antibody progressing into a biomarker-selected tumor-agnostic Phase 1b trial, and (4) AB154, an anti-TIGIT antibody being evaluated in combination with AB122. Arcus has extensive in-house expertise in medicinal chemistry, immunology, biochemistry, pharmacology and structural biology. Utilizing these unique capabilities, Arcus has created a world-class drug discovery organization focused on the development of a growing portfolio of innovative therapies for the treatment of cancer. For more information about Arcus Biosciences, please visit www.arcusbio.com.

Source: Arcus Biosciences

View source version on businesswire.com:https://www.businesswire.com/news/home/20190919005858/en/

CONTACT: Katherine Bock

(510) 694-6231

kbock@arcusbio.com

KEYWORD: CALIFORNIA NEW YORK UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: ONCOLOGY HEALTH CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: Arcus Biosciences

Copyright Business Wire 2019.

PUB: 09/19/2019 04:30 PM/DISC: 09/19/2019 04:31 PM

http://www.businesswire.com/news/home/20190919005858/en

© 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Odessa, TX

Current Conditions

Clear
64°
Humidity: 46%
Winds: WNW at 11mph
Feels Like: 63°

Your Extended Forecast

Tomorrow

weather
High 88°/Low 56°
Clear. Lows overnight in the mid 50s.

saturday

weather
High 80°/Low 55°
Abundant sunshine. Highs in the low 80s and lows in the mid 50s.

sunday

weather
High 89°/Low 50°
Mainly sunny. Highs in the upper 80s and lows in the low 50s.
Online Features

Pet Central

pets

Having a pet is a lot of responsibility, and we’ll help by giving you lots of tips and tricks! More >>

Fitness

Fitness

Our fitness articles will help teach you how to work out with gym- and home-based exercises. More >>

Crosswords

Crosswords

Enjoy the crosswords challenge in our free daily puzzles, from the harder Sunday crossword to the quicker daily. More >>

Sudoku

Sudoku

Every Sudoku has a unique solution that can be reached logically. Enter numbers into the blank spaces so that each row, column and 3x3 box contains the numbers 1 to 9. More >>




  • ALL-ACCESS: Subscribe to our e-edition and premium website at myoaoa.com.
    You can read your daily newspaper without taking a walk to the driveway.
    Look back at yesterday's newspaper, or issues from months ago with our archive feature.
    Call circulation at 432-337-7314 to sign up today.